Suppression of Hypothalamic–Pituitary–Adrenal Axis by Acute Heroin Challenge in Rats During Acute and Chronic Withdrawal from Chronic Heroin Administration

[1]  M. Kreek,et al.  Measuring the incentive value of escalating doses of heroin in heroin-dependent Fischer rats during acute spontaneous withdrawal , 2011, Psychopharmacology.

[2]  R. DiLeone,et al.  Role of orexin/hypocretin in dependence and addiction , 2010, Brain Research.

[3]  V. Yuferov,et al.  Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases , 2010, Brain Research.

[4]  K. Befort,et al.  Reward processing by the opioid system in the brain. , 2009, Physiological reviews.

[5]  K. Brady,et al.  Response to corticotropin-releasing hormone infusion in cocaine-dependent individuals. , 2009, Archives of general psychiatry.

[6]  O. Levran,et al.  Opiate and cocaine addiction: from bench to clinic and back to the bench. , 2009, Current opinion in pharmacology.

[7]  Z. Cooper,et al.  Morphine Deprivation Increases Self-Administration of the Fast- and Short-Acting μ-Opioid Receptor Agonist Remifentanil in the Rat , 2008, Journal of Pharmacology and Experimental Therapeutics.

[8]  G. Aston-Jones.  Faculty Opinions recommendation of Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. , 2008 .

[9]  A. N. van den Pol,et al.  μ-Opioid Receptor-Mediated Depression of the Hypothalamic Hypocretin/Orexin Arousal System , 2008, The Journal of Neuroscience.

[10]  C. Barr,et al.  Mood and Neuroendocrine Response to a Chemical Stressor, Metyrapone, in Buprenorphine-Maintained Heroin Dependence , 2008, Biological Psychiatry.

[11]  F. Leri,et al.  Involvement of Arginine Vasopressin and V1b Receptor in Heroin Withdrawal and Heroin Seeking Precipitated by Stress and by Heroin , 2008, Neuropsychopharmacology.

[12]  E. Costa,et al.  Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats , 2008, Journal of Molecular Neuroscience.

[13]  G. Koob,et al.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence. , 2007, The American journal of psychiatry.

[14]  G. Koob,et al.  Unlimited Access to Heroin Self-Administration: Independent Motivational Markers of Opiate Dependence , 2006, Neuropsychopharmacology.

[15]  M. Kreek,et al.  Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. , 2006, The Journal of endocrinology.

[16]  S. Negus.  Choice between Heroin and Food in Nondependent and Heroin-Dependent Rhesus Monkeys: Effects of Naloxone, Buprenorphine, and Methadone , 2006, Journal of Pharmacology and Experimental Therapeutics.

[17]  R. Sinha,et al.  Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. , 2006, Archives of general psychiatry.

[18]  G. Koob,et al.  Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Aston-Jones,et al.  A role for lateral hypothalamic orexin neurons in reward seeking , 2005, Nature.

[20]  H. Houshyar,et al.  Intermittent Morphine Administration Induces Dependence and is a Chronic Stressor in Rats , 2003, Neuropsychopharmacology.

[21]  A. Burlet,et al.  Quantitative Analysis of Corticotropin‐Releasing Factor and Arginine Vasopressin mRNA in the Hypothalamus During Chronic Morphine Treatment in Rats: An In Situ Hybridization Study , 2003, Journal of neuroendocrinology.

[22]  Jon T. Willie,et al.  Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal , 2003, The Journal of Neuroscience.

[23]  M. Kreek,et al.  Altered HPA Axis Responsivity to Metyrapone Testing in Methadone Maintained Former Heroin Addicts with Ongoing Cocaine Addiction , 2001, Neuropsychopharmacology.

[24]  J. Han,et al.  Hypothalamic-pituitary-adrenal activity and pro-opiomelanocortin mRNA levels in the hypothalamus and pituitary of the rat are differentially modulated by acute intermittent morphine with or without water restriction stress. , 1999, The Journal of endocrinology.

[25]  L. Vanderschuren,et al.  Opioids, reward and addiction: An encounter of biology, psychology, and medicine. , 1999, Pharmacological reviews.

[26]  O. Rønnekleiv,et al.  Proopiomelanocortin (POMC) mRNA expression: distribution and region-specific down-regulation by chronic morphine in female guinea pig hypothalamus. , 1998, Brain research. Molecular brain research.

[27]  J. Culpepper-Morgan,et al.  Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: a case of naloxone-induced withdrawal. , 1997, Metabolism: clinical and experimental.

[28]  S. Wardlaw,et al.  Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. , 1996, Brain research. Molecular brain research.

[29]  M. Kreek.  Opiates, opioids and addiction. , 1996, Molecular psychiatry.

[30]  K. Gudehithlu,et al.  β-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats , 1991, Brain Research.

[31]  C. Kuhn,et al.  Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. , 1990, The Journal of pharmacology and experimental therapeutics.

[32]  K. Carr.  Effects of antibodies to dynorphin A and β-endorphin on lateral hypothalamic self-stimulation in ad libitum fed and food-deprived rats , 1990, Brain Research.

[33]  M. L. Vargas,et al.  Plasma beta-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal. , 1990, European journal of pharmacology.

[34]  H. Akil,et al.  Effects of morphine treatment on pro-opiomelanocortin systems in rat brain , 1990, Brain Research.

[35]  O. Rønnekleiv,et al.  Opioids Hyperpolarize β-Endorphin Neurons via μ-Receptor Activation of a Potassium Conductance , 1990 .

[36]  M. Kelly,et al.  Opioids hyperpolarize beta-endorphin neurons via mu-receptor activation of a potassium conductance. , 1990, Neuroendocrinology.

[37]  M. E. Lewis,et al.  Anatomy of CNS opioid receptors , 1988, Trends in Neurosciences.

[38]  P. Plotsky.  Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats , 1986, Regulatory Peptides.

[39]  T. Kosten,et al.  Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts , 1986, Biological Psychiatry.

[40]  S. Plevy,et al.  ACTH, cortisol and β-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans , 1984, Neuropeptides.

[41]  H. McQuay,et al.  A Controlled Comparison of the Effects of Extradural Diamorphine and Bupivacaine on Plasma Glucose and Plasma Cortisol in Postoperative Patients , 1982, Anesthesia and analgesia.

[42]  J. Buckingham.  Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. , 1982, Neuroendocrinology.

[43]  R. Lanese,et al.  Morphine anesthesia blocks cortisol and growth hormone response to surgical stress in humans. , 1974, The Journal of clinical endocrinology and metabolism.

[44]  M. Kreek.  Medical safety and side effects of methadone in tolerant individuals. , 1973, JAMA.